40 results on '"Bertucci, Emma"'
Search Results
2. First-trimester prediction model for placental vascular disorders: An observational prospective study
- Author
-
Monari, Francesca, Spano' Bascio, Ludovica, Banchelli, Federico, Neri, Isabella, Bertucci, Emma, Ferrari, Francesca, Menichini, Daniela, D'Amico, Roberto, and Facchinetti, Fabio
- Published
- 2022
- Full Text
- View/download PDF
3. Homozygous n.64C>T mutation in mitochondrial RNA-processing endoribonuclease gene causes cartilage hair hypoplasia syndrome in two siblings
- Author
-
Lugli, Licia, Ciancia, Silvia, Bertucci, Emma, Lucaccioni, Laura, Calabrese, Olga, Madeo, Simona, Berardi, Alberto, and Iughetti, Lorenzo
- Published
- 2021
- Full Text
- View/download PDF
4. Outcome of fetal congenital pulmonary malformations: a systematic review and meta-analysis.
- Author
-
Sileo, Filomena Giulia, Alameddine, Sara, Iaccarino, Daniela Anna, Di Mascio, Daniele, Giuliani, Giulia Andrea, Bertucci, Emma, Khalil, Asma, and D'Antonio, Francesco
- Subjects
MEDICAL information storage & retrieval systems ,PRENATAL diagnosis ,LUNGS ,PREGNANCY outcomes ,META-analysis ,DESCRIPTIVE statistics ,LUNG abnormalities ,SYSTEMATIC reviews ,MEDLINE ,MEDICAL databases ,ONLINE information services ,PREGNANCY complications ,FETUS - Abstract
To report the outcome of fetuses with a prenatal diagnosis of congenital lung malformation (CLM) diagnosed on ultrasound by performing a comprehensive assessment of these outcomes through a systematic review and meta-analysis. CLMs are a heterogeneous group of anomalies that involve the lung parenchyma and its bronchovascular structures. Their presentation and evolution are variable, from entirely asymptomatic lesions with sonographic regression in utero to hydropic fetuses requiring fetal therapy, intrauterine death or neonatal morbidity. A systematic review was conducted in Medline, Embase and Cochrane databases including studies on fetuses with CLM diagnosed prenatally in order to report the in-utero natural history of these lesions. Thirty-nine studies (2,638 fetuses) were included in the final review. Regression/reduction in size of the lung lesion during pregnancy was reported in 31 % of cases, while its increase in 8.5 % of cases. Intra-uterine death complicated 1.5 % of pregnancies with fetal CLM, while neonatal and perinatal death were 2.2 and 3 %, respectively. Neonatal morbidity occurred in 20.6 % of newborns with CLM; 46 % had surgery, mainly elective. In fetuses with CLM and hydrops, fetal/perinatal loss occurred in 42 %. Assessment of the role of fetal therapy in improving the outcomes of pregnancies complicated by CLM was hampered by the small number of included cases and heterogeneity of type of interventions. Fetuses with CLM prenatally diagnosed have a generally favorable outcome. Conversely, there is a low quality of evidence on the actual role of fetal therapy in improving the outcome of fetuses presenting with these anomalies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Isthmocele diagnosis: The optimal timing for detection.
- Author
-
Bertucci, Emma, Sileo, Filomena Giulia, Longo, Maria, Tarozzi, Giulia, Benuzzi, Martina, and La Marca, Antonio
- Subjects
- *
MEDICAL sciences , *CESAREAN section , *DIAGNOSTIC ultrasonic imaging , *TRANSVAGINAL ultrasonography , *MENSTRUAL cycle , *UTERINE hemorrhage , *UTERINE rupture , *VAGINAL birth after cesarean , *HYSTEROSCOPY - Abstract
This article discusses the diagnosis of isthmocele, a uterine defect that occurs at the site of a previous cesarean section or other uterine surgeries. It affects up to 70% of women with a history of cesarean sections and can cause symptoms such as abnormal uterine bleeding and abdominal pain. Accurate diagnosis is important as isthmocele has been linked to complications in future pregnancies. Transvaginal ultrasonography is the primary diagnostic method, and the study suggests that performing the ultrasound during the secretive phase of the menstrual cycle provides clearer visualization of the isthmocele. Surgical correction can be done depending on the size of the defect. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
6. Prenatal ultrasound signs of Aarskog‐Scott syndrome in a twin pregnancy: A case report.
- Author
-
Bertucci, Emma, Giulini, Simone, Sighinolfi, Giovanna, Benuzzi, Martina, and Lugli, Licia
- Subjects
- *
MULTIPLE pregnancy , *FETOFETAL transfusion , *ULTRASONIC imaging , *SYNDROMES - Abstract
Synopsis: We describe the case of Aarskog‐Scott syndrome in a twin pregnancy with the prenatal finding of shortened fetal long bones. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Pre- and post-natal growth in two sisters with 3-M syndrome
- Author
-
Lugli, Licia, Bertucci, Emma, Mazza, Vincenzo, Elmakky, Amira, Ferrari, Fabrizio, Neuhaus, Christine, and Percesepe, Antonio
- Published
- 2016
- Full Text
- View/download PDF
8. Healthy preterm newborns: Altered innate immunity and impaired monocyte function.
- Author
-
De Biasi, Sara, Neroni, Anita, Nasi, Milena, Lo Tartaro, Domenico, Borella, Rebecca, Gibellini, Lara, Lucaccioni, Laura, Bertucci, Emma, Lugli, Licia, Miselli, Francesca, Bedetti, Luca, Neri, Isabella, Ferrari, Fabrizio, Facchinetti, Fabio, Berardi, Alberto, and Cossarizza, Andrea
- Subjects
NATURAL immunity ,NEWBORN infants ,KILLER cells ,NEONATAL infections ,DISEASE susceptibility - Abstract
Birth prior to 37 completed weeks of gestation is referred to as preterm (PT). Premature newborns are at increased risk of developing infections as neonatal immunity is a developing structure. Monocytes, which are key players after birth, activate inflammasomes. Investigations into the identification of innate immune profiles in premature compared to full‐term infants are limited. Our research includes the investigation of monocytes and NK cells, gene expression, and plasma cytokine levels to investigate any potential differences among a cohort of 68 healthy PT and full‐term infants. According to high‐dimensional flow cytometry, PT infants have higher proportions of CD56+/−CD16+NK cells and immature monocytes, and lower proportions of classical monocytes. Gene expression revealed lower proportions of inflammasome activation after in vitro monocyte stimulation and the quantification of plasma cytokine levels expressed higher concentrations of alarmin S100A8. Our findings suggest that PT newborns have altered innate immunity and monocyte functional impairment, and pro‐inflammatory plasmatic profile. This may explain PT infants' increased susceptibility to infectious disease and should pave the way for novel therapeutic strategies and clinical interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. How adenomyosis changes throughout pregnancy: A retrospective cohort study.
- Author
-
Bertucci, Emma, Sileo, Filomena G., Diamanti, Marialaura, Alboni, Carlo, Facchinetti, Fabio, and La Marca, Antonio
- Subjects
- *
ENDOMETRIOSIS , *MANN Whitney U Test , *COHORT analysis , *MATERNAL age , *PREGNANCY - Abstract
Objective: To study how adenomyosis changes during pregnancy and to possibly correlate these changes to maternal and fetal outcomes. Methods: Retrospective exploratory cohort study including 254 women with a pre‐conceptional/first‐trimester scan to document adenomyosis and known obstetric outcome. If visible, adenomyosis signs were documented in each trimester and postpartum. Mann–Whitney U tests or χ2 tests were used for continuous and categorical variables, respectively. Results: A globular uterus was reported in 79% (n = 52) of women with adenomyosis in the first trimester, in 38% (n = 20) and 2% (n = 1) of women in the second and third trimesters, respectively, and postpartum in 77% (n = 34) of women. Asymmetrical thickening (n = 20, 30%) and cysts (n = 15, 23%) were only visible in 1st trimester. Adenomyosis was associated with miscarriage (odds ratio [OR] 5.9, 95% confidence interval [CI] 2.4–14.9, P < 0.001) also in normal conception only (OR 5.1, 95% CI 1.8–14.2, P = 0.002) or adjusting for maternal age (adjusted OR 5.9, 95% CI 2.3–15.2, P < 0.001). Gestational age at delivery was lower in adenomyosis (P = 0.004); the cesarean section rate was higher than in controls (OR 2.5, 95% CI 1.3–4.8, P = 0.007) also adjusting for age (adjusted OR 2.07, 95% CI 1.06–4.08, P = 0.035). Conclusions: Signs of adenomyosis were visible but progressively disappeared in pregnancy; adenomyosis was associated with an increased risk of early miscarriage. Prospective studies are needed to confirm our results. Synopsis: Sonographic signs of adenomyosis are visible in pregnancy although they progressively disappear; adenomyosis was associated with an increased risk of early miscarriage. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Human Neuromuscular Junction on a Chip: Impact of Amniotic Fluid Stem Cell Extracellular Vesicles on Muscle Atrophy and NMJ Integrity.
- Author
-
Gatti, Martina, Dittlau, Katarina Stoklund, Beretti, Francesca, Yedigaryan, Laura, Zavatti, Manuela, Cortelli, Pietro, Palumbo, Carla, Bertucci, Emma, Van Den Bosch, Ludo, Sampaolesi, Maurilio, and Maraldi, Tullia
- Subjects
MUSCULAR atrophy ,MYONEURAL junction ,AMNIOTIC liquid ,EXTRACELLULAR vesicles ,STEM cells - Abstract
Neuromuscular junctions (NMJs) are specialized synapses, crucial for the communication between spinal motor neurons (MNs) and skeletal muscle. NMJs become vulnerable in degenerative diseases, such as muscle atrophy, where the crosstalk between the different cell populations fails, and the regenerative ability of the entire tissue is hampered. How skeletal muscle sends retrograde signals to MNs through NMJs represents an intriguing field of research, and the role of oxidative stress and its sources remain poorly understood. Recent works demonstrate the myofiber regeneration potential of stem cells, including amniotic fluid stem cells (AFSC), and secreted extracellular vesicles (EVs) as cell-free therapy. To study NMJ perturbations during muscle atrophy, we generated an MN/myotube co-culture system through Xona
TM microfluidic devices, and muscle atrophy was induced in vitro by Dexamethasone (Dexa). After atrophy induction, we treated muscle and MN compartments with AFSC-derived EVs (AFSC-EVs) to investigate their regenerative and anti-oxidative potential in counteracting NMJ alterations. We found that the presence of EVs reduced morphological and functional in vitro defects induced by Dexa. Interestingly, oxidative stress, occurring in atrophic myotubes and thus involving neurites as well, was prevented by EV treatment. Here, we provided and validated a fluidically isolated system represented by microfluidic devices for studying human MN and myotube interactions in healthy and Dexa-induced atrophic conditions—allowing the isolation of subcellular compartments for region-specific analyses—and demonstrated the efficacy of AFSC-EVs in counteracting NMJ perturbations. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
11. De novo variants and recombination at 4q35: Hints for preimplantation genetic testing in facioscapulohumeral muscular dystrophy.
- Author
-
Pini, Sara, Napoli, Floriana Maria, Tagliafico, Enrico, La Marca, Antonio, Bertucci, Emma, Salsi, Valentina, and Tupler, Rossella
- Subjects
FACIOSCAPULOHUMERAL muscular dystrophy ,GENETIC testing ,CHORIONIC villi ,DNA analysis - Abstract
Facioscapulohumeral muscular dystrophy (FSHD) has been associated with the deletion of an integral number of 3.3 kb units of the polymorphic D4Z4 repeat array at 4q35. The prenatal identification of this defect can be carried out on chorionic villi or amniocytes, whereas preimplantation genetic testing for monogenic disorders (PGT‐M) requires molecular markers linked to the D4Z4 allele of reduced size. In this context the reliability of this association is crucial. To test the informativeness of the nearby polymorphic markers we investigated recombination at 4q35 using the polymorphic markers D4S1523, D4S163 and D4S139 positioned at 0.55, 0.5 and 0.21 Mb proximal to the D4Z4 array respectively. We determined the probability of recombination events to occur in the D4Z4‐D4S1523 interval considering 86 subjects belonging to 12 FSHD families and found a recombination frequency of 14% between D4Z4 and D4S1523. Our study also revealed the occurrence of de novo variants and germline mosaicism. These findings highlight the recombinogenic nature of the 4q subtelomere and indicate that caution should be taken when interpreting PGT‐M results. It is advisable that a woman who underwent a PGT‐M cycle undertakes a prenatal DNA analysis to confirm the size of the D4Z4 alleles carried by the fetus. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Effect of the Enrichment in c-Kit Stem Cell Potential of Foetal Human Amniotic Fluid Cells: Characterization from Single Cell Analysis to the Secretome Content.
- Author
-
Casciaro, Francesca, Beretti, Francesca, Gatti, Martina, Persico, Giuseppe, Bertucci, Emma, Giorgio, Marco, and Maraldi, Tullia
- Subjects
AMNIOTIC liquid ,C-kit protein ,STEM cells ,MULTIPOTENT stem cells ,CELL analysis - Abstract
Human amniotic fluid cells (hAFSCs) are a fascinating foetal cell-type that have important stem cell characteristics; however, they are a heterogeneous population that ranges from totally differentiated or progenitor cells to highly multipotent stem cells. There is no single approach to isolating the stem cell component, but the selection of a subpopulation of hAFSCs expressing c-Kit is widely employed, while a deep characterization of the two populations is still lacking. Here we performed single-cell and bulk RNAseq analysis to compare the gene expression profiles of adherent amniotic fluid cells and their subpopulation c-Kit
+ . Information deriving from this high throughput technology on the transcriptome was then confirmed for specific targets with protein expression experiments and functional analysis. In particular, transcriptome profiling identified changes in cellular distribution among the different clusters that correlated with significant differential expression in pathways related to stemness, proliferation, and cell cycle checkpoints. These differences were validated by RT-PCR, immunofluorescence, WB, and cell cycle assays. Interestingly, the two populations produced secretomes with different immune-modulating and pro-regenerative potentials. Indeed, the presence of TGFβ, HGF, IDO was higher in EVs deriving from c-Kit+ cells, unlike IL-6. These results suggest the existence of deep intra-population differences that can influence the stemness profile of hAFSCs. This study represents a proof-of-concept of the importance of selecting c-Kit positive fractions with higher potential in regenerative medicine applications. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
13. Ultrasound screening for fetal anomalies in a single center: diagnostic performances twenty years after the Eurofetus Study.
- Author
-
Sileo, Filomena G., Finarelli, Alessandra, Contu, Giannina, Lugli, Licia, Dipace, Vincenza, Ballarini, Michela, Guidi, Cristina, Facchinetti, Fabio, and Bertucci, Emma
- Subjects
FETAL abnormalities ,FETAL ultrasonic imaging ,ABORTION ,HUMAN abnormalities ,PRENATAL diagnosis ,POSTMORTEM changes - Abstract
Purpose: To establish the accuracy of ultrasound in detecting fetal anomalies looking at the concordance between prenatal and postnatal diagnosis. Materials and methods: Retrospective analysis of concordance between prenatal and postnatal/autoptic diagnosis of fetuses with congenital abnormalities. Data are from a single center (Policlinico di Modena); all fetuses included were born between 2017 and 2018 and with a follow-up of at least 6 months. We included all deliveries (including perinatal deaths) and termination of pregnancy (TOP) for fetal indication. We calculated sensibility, sensitivity, Positive and Negative Likelihood Ratio, positive and negative predictive value of ultrasound. Results: During the study period 5920 deliveries, including perinatal deaths, and 28 TOP for fetal indication were registered at our center. The prevalence of congenital malformations was 2.6% (153/5920). At least one ultrasound was performed in our center in 1250 women delivering in our unit. All 28 TOP had the anomaly scan performed in our center. Among the total 1278 women scanned in our unit, there were 128 (10%) suspicious scans. In 5/128 (3.9%) cases we diagnosed a false alarm; in 8/128 (6.2%) cases an evolutive malformation with in-utero regression. The prenatal diagnosis was confirmed in 77 (60.2%) cases at birth and in 28/128 (21.9%) at postmortem analysis while there were 10/128 false positive (7.8%). Among the 153 congenital malformations diagnosed at birth, the anomaly scan was performed in our Prenatal Medicine Unit in 92 (60.1%) fetuses. Among these, there were 15 false negatives (9.8%) while in 77/92 (83.7%) the malformation at birth agreed with the sonographic diagnosis. Sensitivity and specificity of ultrasound were 87.5% (IC95 80.2-92.8%) and 99.1% (IC95 98.4-99.6%) respectively with a Positive Likelihood Ratio and Negative Likelihood Ratio of 101.3 (IC95 54.5-188.5) and 0.13 (IC95 0.08-0.2); Positive Predictive Value and Negative Predictive Value were 91.3% (IC95 85-95.1%) and 98.7(IC95 98-99.2%). Conclusion: Anomaly scan in pregnancy allows the diagnosis of congenital malformations with a sensibility of 87.5% and specificity of 99.1%. The main limitations of this study are its retrospective design and that it was conducted in a single referral center. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Diagnostic performance of cerebroplacental and umbilicocerebral ratio in appropriate for gestational age and late growth restricted fetuses attempting vaginal delivery: a multicenter, retrospective study.
- Author
-
Villalain, Cecilia, Galindo, Alberto, Di Mascio, Daniele, Buca, Danilo, Morales-Rosello, Jose, Loscalzo, Gabriela, Sileo, Filomena Giulia, Finarelli, Alessandra, Bertucci, Emma, Facchinetti, Fabio, Rizzo, Giuseppe, Brunelli, Roberto, Giancotti, Antonella, Muzii, Ludovico, Maruotti, Giuseppe Maria, Carbone, Luigi, D’Amico, Alice, Tinari, Sara, Morelli, Roberta, and Cerra, Chiara
- Subjects
DELIVERY (Obstetrics) ,GESTATIONAL age ,FETAL development ,PLACENTAL growth factor ,NEONATAL intensive care units ,FETAL growth retardation - Abstract
Background Cerebroplacental Doppler studies have been advocated to predict the risk of adverse perinatal outcome (APO) irrespective of fetal weight. Objective To report the diagnostic performance of cerebroplacental (CPR) and umbilicocerebral (UCR) ratios in predicting APO in appropriate for gestational age (AGA) fetuses and in those affected by late fetal growth restriction (FGR) attempting vaginal delivery. Study design Multicenter, retrospective, nested case-control study between 1 January 2017 and January 2020 involving five referral centers in Italy and Spain. Singleton gestations with a scan between 36 and 40 weeks and within two weeks of attempting vaginal delivery were included. Fetal arterial Doppler and biometry were collected. The AGA group was defined as fetuses with an estimated fetal weight and abdominal circumference >10th and <90th percentile, while the late FGR group was defined by Delphi consensus criteria. The primary outcome was the prediction of a composite of perinatal adverse outcomes including either intrauterine death, Apgar score at 5 min <7, abnormal acid-base status (umbilical artery pH < 7.1 or base excess of more than −11) and neonatal intensive care unit (NICU) admission. Area under the curve (AUC) analysis was performed. Results 646 pregnancies (317 in the AGA group and 329 in the late FGR group) were included. APO were present in 12.6% AGA and 24.3% late FGR pregnancies, with an odds ratio of 2.22 (95% CI 1.46–3.37). The performance of CPR and UCR for predicting APO was poor in both AGA [AUC: 0.44 (0.39–0.51)] and late FGR fetuses [AUC: 0.56 (0.49–0.61)]. Conclusions CPR and UCR on their own are poor prognostic predictors of APO irrespective of fetal weight. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Implementation of guidelines about women with previous cesarean section through educational/motivational interventions.
- Author
-
Monari, Francesca, Menichini, Daniela, Bertucci, Emma, Neri, Isabella, Perrone, Enrica, and Facchinetti, Fabio
- Published
- 2022
- Full Text
- View/download PDF
16. Prenatal diagnosis and follow-up of a case of branchio-oto-renal syndrome displays renal growth impairment after the second trimester
- Author
-
Bertucci, Emma, Mazza, Vincenzo, Lugli, Licia, Ferrari, Fabrizio, Stanghellini, Ilaria, and Percesepe, Antonio
- Published
- 2015
- Full Text
- View/download PDF
17. Complete hydatidiform mole in higher-order multiple pregnancies.
- Author
-
SILEO, Filomena G., GIULIANI, Giulia A., FACCHINETTI, Fabio, CONTU, Giannina, CHIOSSI, Giuseppe, and BERTUCCI, Emma
- Subjects
TWINS ,MOLAR pregnancy ,CHORIOCARCINOMA ,HYPERTHYROIDISM ,X-rays - Published
- 2022
- Full Text
- View/download PDF
18. Counseling and prenatal diagnosis in facioscapulohumeral muscular dystrophy: A retrospective study on a 13‐year multidisciplinary approach.
- Author
-
Di Feo, Maria Francesca, Bettio, Cinzia, Salsi, Valentina, Bertucci, Emma, and Tupler, Rossella
- Subjects
FACIOSCAPULOHUMERAL muscular dystrophy ,PRENATAL diagnosis ,GENETIC counseling ,COUNSELING ,CHORIONIC villus sampling - Abstract
Background and Aims: This is the first national population‐based report about prenatal diagnosis for families with a history of facioscapulohumeral muscular dystrophy (FSHD), a complex hereditary disease. The incomplete disease penetrance and the phenotypic heterogeneity observed in carriers of D4Z4 alleles of reduced size, the FSHD molecular hallmark, make the estimate of genetic risk problematic. Methods: We considered all requests of preconception counseling and prenatal diagnosis received between January 2008 and December 2020 by the genetic counseling service associated with the Italian National Registry for FSHD (INRF). A multidisciplinary team managed the clinical and molecular data of each family. Results: Between 2008 and 2020, 60 couples required preconception counseling (PC) for FSHD. In 52 couples was observed at least one partner carried a D4Z4 reduced allele (DRA). Out of these 52 couples, 47 had a follow‐up visit routine yearly. Out of these 47, 26 (55.3%) couples had children: eight asked for prenatal diagnosis (PND), two had assisted reproduction by heterologous in vitro fertilization (IVF), and 16 did not require further assistance. Regarding PND, 50 prenatal analyses were performed for 36 couples. The test resulted positive in 27 pregnancies, 12 (44.4%) were terminated, and 15 (55.6%) were carried to term. Conclusion: The different choices made by the couples show the importance of an integrated approach to support genetic counseling for FSHD. These results remark the relevance of the clinical and molecular investigation of the extended family, preferably before conception. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. First-trimester ultrasonographic diagnosis of Langer mesomelic dysplasia in a previouslyaffected family
- Author
-
Mazza, Vincenzo, Latella, Silvia, Pati, Mariangela, Re, Claudia, Bertucci, Emma, Cani, Carlotta, and Percesepe, Antonio
- Published
- 2011
- Full Text
- View/download PDF
20. Familial Beckwith-Wiedemann syndrome due to CDKN1C mutation manifesting with recurring omphalocele
- Author
-
Percesepe, Antonio, Bertucci, Emma, Ferrari, Paola, Lugli, Licia, Ferrari, Fabrizio, Mazza, Vincenzo, and Forabosco, Antonino
- Published
- 2008
- Full Text
- View/download PDF
21. Preterm delivery and exposure to active and passive smoking during pregnancy: a case–control study from Italy
- Author
-
Fantuzzi, Guglielmina, Aggazzotti, Gabriella, Righi, Elena, Facchinetti, Fabio, Bertucci, Emma, Kanitz, Stefano, Barbone, Fabio, Sansebastiano, Giuliano, Battaglia, Mario Alberto, Leoni, Valerio, Fabiani, Leila, Triassi, Maria, and Sciacca, Salvatore
- Published
- 2007
22. Age-specific risk of fetal loss post second trimester amniocentesis: analysis of 5043 cases
- Author
-
Mazza, Vincenzo, Pati, Mariangela, Bertucci, Emma, Re, Claudia, Ranzi, Andrea, Percesepe, Antonio, Forabosco, Antonino, and Volpe, Annibale
- Published
- 2007
- Full Text
- View/download PDF
23. Maternal and neonatal outcomes of pregnancies complicated by late fetal growth restriction undergoing induction of labor with dinoprostone compared with cervical balloon: A retrospective, international study.
- Author
-
Di Mascio, Daniele, Villalain, Cecilia, Rizzo, Giuseppe, Morales‐Rossello, Jose, Sileo, Filomena G., Maruotti, Giuseppe M., Prefumo, Federico, Galindo, Alberto, D'Antonio, Francesco, Buca, Danilo, Herraiz, Ignacio, Loscalzo, Gabriela, Sileo, Filomena G, Finarelli, Alessandra, Bertucci, Emma, Facchinetti, Fabio, Brunelli, Roberto, Giancotti, Antonella, Muzii, Ludovico, and Maruotti, Giuseppe M
- Subjects
FETAL growth retardation ,PREGNANCY outcomes ,CESAREAN section ,DELIVERY (Obstetrics) ,DINOPROSTONE ,INDUCED labor (Obstetrics) ,NEONATAL surgery - Abstract
Introduction: The aim of this study was to compare vaginal dinoprostone and mechanical methods for induction of labor (IOL) in pregnancies complicated by late fetal growth restriction. Material and methods: Multicenter, retrospective, cohort study involving six referral centers in Italy and Spain. Inclusion criteria were pregnancies complicated by late fetal growth restriction as defined by Delphi consensus criteria. The primary outcome was the occurrence of uterine tachysystole; secondary outcomes were either cesarean delivery or operative vaginal delivery for non‐reassuring fetal status, a composite score of adverse neonatal outcome and admission to neonatal intensive care unit (NICU). Univariate and multivariate logistic regression analysis was used to analyze the data. Results: A total of 571 pregnancies complicated by late fetal growth restriction undergoing IOL (391 with dinoprostone and 180 with mechanical methods) were included in the analysis. The incidence of uterine tachysystole (19.2% vs. 5.6%; p = 0.001) was higher in women undergoing IOL with dinoprostone than in those undergoing IOL with mechanical methods. Similarly, the incidence of cesarean delivery or operative delivery for non‐reassuring fetal status (25.6% vs. 17.2%; p = 0.027), composite adverse neonatal outcome (26.1% vs. 16.7%; p = 0.013) and NICU admission (16.9% vs. 5.6%; p < 0.001) was higher in women undergoing IOL with dinoprostone than in those undergoing IOL with mechanical methods. At logistic regression analysis, IOL with mechanical methods was associated with a significantly lower risk of uterine tachysystole (odds ratio 0.26, 95% confidence interval 0.13‐0.54; p < 0.001). Conclusions: In pregnancies complicated by late fetal growth restriction, IOL with mechanical methods is associated with a lower risk of uterine tachysystole, cesarean delivery or operative delivery for non‐reassuring fetal status, and adverse neonatal outcome compared with pharmacological methods. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. Role of prenatal magnetic resonance imaging in fetuses with isolated anomalies of corpus callosum: multinational study.
- Author
-
Sileo, Filomena Giulia, Pilu, Gianluigi, Prayer, Daniela, Rizzo, Giuseppe, Khalil, Asma, Managanaro, Lucia, Volpe, Paolo, Van Mieghem, Tim, Bertucci, Emma, Morales Roselló, José, Facchinetti, Fabio, Di Mascio, Daniele, Stampalija, Tamara, Buca, Danilo, Tinari, Sara, Oronzi, Ludovica, Ercolani, Giada, D'Amico, Alice, Matarrelli, Barbara, and Cerra, Chiara
- Subjects
FETAL MRI ,AGENESIS of corpus callosum ,CORPUS callosum ,ULTRASONIC imaging ,AUTOPSY ,PRENATAL diagnosis - Abstract
Objective: To assess the performance of fetal magnetic resonance imaging (MRI) in detecting associated anomalies in fetuses diagnosed with isolated corpus callosal (CC) anomaly on multiplanar ultrasound evaluation of the fetal brain (neurosonography).Methods: This was a multicenter, retrospective cohort study involving 14 fetal medicine centers in Italy, UK, Portugal, Canada, Austria and Spain. Inclusion criteria were fetuses with an apparently isolated CC anomaly, defined as an anomaly of the CC and no other additional central nervous system (CNS) or extra-CNS abnormality detected on expert ultrasound, including multiplanar neurosonography; normal karyotype; maternal age ≥ 18 years; and gestational age at diagnosis ≥ 18 weeks. The primary outcome was the rate of additional CNS abnormalities detected exclusively on fetal MRI within 2 weeks following neurosonography. The secondary outcomes were the rate of additional abnormalities according to the type of CC abnormality (complete (cACC) or partial (pACC) agenesis of the CC) and the rate of additional anomalies detected only on postnatal imaging or at postmortem examination.Results: A total of 269 fetuses with a sonographic prenatal diagnosis of apparently isolated CC anomalies (207 with cACC and 62 with pACC) were included in the analysis. Additional structural anomalies of the CNS were detected exclusively on prenatal MRI in 11.2% (30/269) of cases, with malformations of cortical development representing the most common type of anomaly. When stratifying the analysis according to the type of CC anomaly, the rate of associated anomalies detected exclusively on MRI was 11.6% (24/207) in cACC cases and 9.7% (6/62) in pACC cases. On multivariate logistic regression analysis, only maternal body mass index was associated independently with the likelihood of detecting associated anomalies on MRI (odds ratio, 1.07 (95% CI, 1.01-1.14); P = 0.03). Associated anomalies were detected exclusively after delivery and were missed on both types of prenatal imaging in 3.9% (8/205) of fetuses with prenatal diagnosis of isolated anomaly of the CC.Conclusion: In fetuses with isolated anomaly of the CC diagnosed on antenatal neurosonography, MRI can identify a small proportion of additional anomalies, mainly malformations of cortical development, which are not detected on ultrasound. © 2021 International Society of Ultrasound in Obstetrics and Gynecology. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
25. Comparison between Cerebroplacental Ratio and Umbilicocerebral Ratio in Predicting Adverse Perinatal Outcome in Pregnancies Complicated by Late Fetal Growth Restriction: A Multicenter, Retrospective Study.
- Author
-
Di Mascio, Daniele, Herraiz, Ignacio, Villalain, Cecilia, Buca, Danilo, Morales-Rossello, Jose, Loscalzo, Gabriela, Sileo, Filomena Giulia, Finarelli, Alessandra, Bertucci, Emma, Facchinetti, Fabio, Rizzo, Giuseppe, Brunelli, Roberto, Giancotti, Antonella, Muzii, Ludovico, Maruotti, Giuseppe Maria, Carbone, Luigi, D'Amico, Alice, Tinari, Sara, Morelli, Roberta, and Cerra, Chiara
- Subjects
PREGNANCY outcomes ,FETAL growth retardation ,DELIVERY (Obstetrics) ,ABSOLUTE value ,CESAREAN section - Abstract
Introduction: The role of cerebroplacental ratio (CPR) or umbilicocerebral ratio (UCR) to predict adverse intrapartum and perinatal outcomes in pregnancies complicated by late fetal growth restriction (FGR) remains controversial. Methods: This was a multicenter, retrospective cohort study involving 5 referral centers in Italy and Spain, including singleton pregnancies complicated by late FGR, as defined by Delphi consensus criteria, with a scan 1 week prior to delivery. The primary objective was to compare the diagnostic accuracy of the CPR and UCR for the prediction of a composite adverse outcome, defined as the presence of either an adverse intrapartum outcome (need for operative delivery/cesarean section for suspected fetal distress) or an adverse perinatal outcome (intrauterine death, Apgar score <7 at 5 min, arterial pH <7.1, base excess of >−11 mEq/mL, or neonatal intensive care unit admission). Results: Median CPR absolute values (1.11 vs. 1.22, p = 0.018) and centiles (3 vs. 4, p = 0.028) were lower in pregnancies with a composite adverse outcome than in those without it. Median UCR absolute values (0.89 vs. 0.82, p = 0.018) and centiles (97 vs. 96, p = 0.028) were higher. However, the area under the curve, 95% confidence interval for predicting the composite adverse outcome showed a poor predictive value: 0.580 (0.512–0.646) for the raw absolute values of CPR and UCR, and 0.575 (0.507–0.642) for CPR and UCR centiles adjusted for gestational age. The use of dichotomized values (CPR <1, UCR >1 or CPR <5th centile, UCR >95th centile) did not improve the diagnostic accuracy. Conclusion: The CPR and UCR measured in the week prior delivery are of low predictive value to assess adverse intrapartum and perinatal outcomes in pregnancies with late FGR. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
26. Disorder of sex development associated with a novel homozygous nonsense mutation in COG6 expands the phenotypic spectrum of COG6-CDG.
- Author
-
Lugli, Licia, Bariola, Maria Carolina, Ferri, Lorenzo, Lucaccioni, Laura, Bertucci, Emma, Cattini, Umberto, Torcetta, Francesco, Morrone, Amelia, Iughetti, Lorenzo, and Berardi, Alberto
- Abstract
Congenital disorders of glycosylation (CDG) are an expanding group of metabolic disorders that result from abnormal protein glycosylation. A special subgroup of CDG type II comprises defects in the Conserved Oligomeric Golgi Complex (COG). In order to further delineate the genotypic and phenotypic spectrum of COG complex defect, we describe a novel variant of COG6 gene found in homozygosity in a Moroccan patient with severe presentation of COG6‐CDG (OMIM #614576). We compared the phenotype of our patient with other previously reported COG6‐CDG cases. Common features in COG6‐CDG are facial dysmorphism, growth retardation, microcephaly, developmental disability, liver or gastrointestinal disease, recurrent infections, hypohidrosis/hyperthermia. In addition to these phenotypic features, our patient exhibited a disorder of sexual differentiation, which has rarely been reported in COG6‐CDG. We hypothesize that the severe COG6 gene mutation interferes with glycosylation of a disintegrin and metalloprotease family members, inhibiting the correct gonadal distal tip cells migration, fundamental for the genitalia morphogenesis. This report broadens the genetic and phenotypic spectrum of COG6‐CDG and provides further supportive evidence that COG6‐CDG can present as a disorder of sexual differentiation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
27. Pregnant woman infected by Coronavirus disease (COVID-19) and calcifications of the fetal bowel and gallbladder.
- Author
-
SILEO, Filomena G., TRAMONTANO, Anna L., LEONE, Chiara, MEACCI, Marisa, GENNARI, William, TERNELLI, Giliana, LA MARCA, Antonio, LUGLI, Licia, BERARDI, Alberto, FACCHINETTI, Fabio, and BERTUCCI, Emma
- Subjects
CORONAVIRUS diseases ,PREGNANCY complications ,ULTRASONIC imaging ,FETUS ,GALLBLADDER - Published
- 2021
- Full Text
- View/download PDF
28. Corticotropin-releasing hormone, its binding protein and receptors in human cervical tissue at preterm and term labor in comparison to non-pregnant state
- Author
-
Byström Birgitta, Stjernholm-Vladic Ylva, Abelin-Tornblöm Susanne, Bertucci Emma, Calciolari Jacopo, Klimaviciute Aurelija, Petraglia Felice, and Ekman-Ordeberg Gunvor
- Subjects
Gynecology and obstetrics ,RG1-991 ,Reproduction ,QH471-489 - Abstract
Abstract Background Preterm birth is still the leading cause of neonatal morbidity and mortality. The level of corticotropin-releasing hormone (CRH) is known to be significantly elevated in the maternal plasma at preterm birth. Although, CRH, CRH-binding protein (CRH-BP), CRH-receptor 1 (CRH-R1) and CRH-R2 have been identified both at mRNA and protein level in human placenta, deciduas, fetal membranes, endometrium and myometrium, no corresponding information is yet available on cervix. Thus, the aim of this study was to compare the levels of the mRNA species coding for CRH, CRH-BP, CRH-R1 and CRH-R2 in human cervical tissue and myometrium at preterm and term labor and not in labor as well as in the non-pregnant state, and to localize the corresponding proteins employing immunohistochemical analysis. Methods Cervical, isthmic and fundal (from non-pregnant subjects only) biopsies were taken from 67 women. Subjects were divided in 5 groups: preterm labor (14), preterm not in labor (7), term labor (18), term not in labor (21) and non-pregnant (7). Real-time RT-PCR was employed for quantification of mRNA levels and the corresponding proteins were localized by immunohistochemical analysis. Results The levels of CRH-BP, CRH-R1 and CRH-R2 mRNA in the pregnant tissues were lower than those in non-pregnant subjects. No significant differences were observed between preterm and term groups. CRH-BP and CRH-R2 mRNA and the corresponding proteins were present at lower levels in the laboring cervix than in the non-laboring cervix, irrespective of gestational age. In most of the samples, with the exception of four myometrial biopsies the level of CRH mRNA was below the limit of detection. All of these proteins could be detected and localized in the cervix and the myometrium by immunohistochemical analysis. Conclusion Expression of CRH-BP, CRH-R1 and CRH-R2 in uterine tissues is down-regulated during pregnancy. The most pronounced down-regulation of CRH-BP and CRH-R2 occurred in laboring cervix, irrespective the length of gestation. The detection of substantial expression of the CRH and its receptor proteins, as well as receptor mRNA in the cervix suggests that the cervix may be a target for CRH action. Further studies are required to elucidate the role of CRH in cervical ripening.
- Published
- 2006
- Full Text
- View/download PDF
29. Role of prenatal magnetic resonance imaging in fetuses with isolated agenesis of corpus callosum in the era of fetal neurosonography: A systematic review and meta‐analysis.
- Author
-
Sileo, Filomena Giulia, Di Mascio, Daniele, Rizzo, Giuseppe, Caulo, Massimo, Manganaro, Lucia, Bertucci, Emma, Masmejan, Sophie, Liberati, Marco, D'Amico, Alice, Nappi, Luigi, Buca, Danilo, Van Mieghem, Tim, Khalil, Asma, and D'Antonio, Francesco
- Subjects
FETAL MRI ,AGENESIS of corpus callosum ,FETAL abnormalities ,PRENATAL diagnosis ,GESTATIONAL age - Abstract
Introduction: Corpus callosum agenesis (ACC) is frequently diagnosed during fetal life; its prognosis depends also on additional anomalies. The additional value of fetal magnetic resonance imaging (MRI) in fetuses with "isolated" complete (cACC) and partial (pACC) agenesis of the corpus callosum on ultrasound is still debated. Material and methods: We performed a systematic literature review and meta‐analysis including fetuses with a prenatal diagnosis of cACC and pACC without associated structural anomalies on ultrasound, undergoing fetal MRI. The primary outcome was the rate of additional anomalies detected at fetal MRI. Further analyses assessed the effect of type of ultrasound assessment (neurosonography vs standard axial assessment), gestational age at fetal MRI and rate of postnatally detected brain anomalies. Random‐effect meta‐analyses of proportions were used to analyze the data. Results: Fourteen studies (798 fetuses) were included. In cases with isolated cACC, 10.9% (95% CI 4.1‐20.6) and 4.3% (95% CI 1.4‐8.8) additional anomalies were detected by fetal MRI and postnatally, respectively. Stratifying according to the type of ultrasound assessment, the rate of associated anomalies detected only on fetal MRI was 5.7% (95% CI 0.5‐16.0) with dedicated neurosonography and 18.5% (95% CI 7.8‐32.4) with a standard axial assessment. In fetuses with isolated pACC, 13.4% (95% CI 4.0‐27.0) and 16.2% (95% CI 5.9‐30.3) additional anomalies were detected by fetal MRI or postnatally, respectively. Stratifying according to the type of ultrasound assessment, the rate of associated anomalies detected only on fetal MRI was 11.4% (95% CI 2.7‐25.0) when dedicated neurosonography was performed. Cortical and posterior fossa anomalies represented the most common anomalies missed at ultrasound with both cACC and pACC. Due to the very small number of included cases, stratification according to early (<24 weeks of gestation) and late (>24 weeks) fetal MRI could not be done for either cACC or pACC. Conclusions: The rate of associated anomalies detected exclusively at fetal MRI in isolated ACC undergoing neurosonography is lower than previously reported. Cortical and posterior fossa anomalies are among the most common anomalies detected exclusively at MRI, thus confirming the crucial role of fetal MRI in determining the prognosis of these fetuses. However, some anomalies still go undetected prenatally and this should be stressed during parental counseling. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
30. Oxidative Stress in Alzheimer's Disease: In Vitro Therapeutic Effect of Amniotic Fluid Stem Cells Extracellular Vesicles.
- Author
-
Gatti, Martina, Zavatti, Manuela, Beretti, Francesca, Giuliani, Daniela, Vandini, Eleonora, Ottani, Alessandra, Bertucci, Emma, and Maraldi, Tullia
- Published
- 2020
- Full Text
- View/download PDF
31. Comparison of the therapeutic effect of amniotic fluid stem cells and their exosomes on monoiodoacetate‐induced animal model of osteoarthritis.
- Author
-
Zavatti, Manuela, Beretti, Francesca, Casciaro, Francesca, Bertucci, Emma, and Maraldi, Tullia
- Subjects
AMNIOTIC liquid ,TREATMENT effectiveness ,STEM cells ,EXOSOMES ,ARTICULAR cartilage ,ANIMAL models in research ,OSTEOARTHRITIS ,TRANSFORMING growth factors-beta - Abstract
The cartilage tissue engineering associated with stem cell‐related therapies is becoming very interesting since adult articular cartilage has limited intrinsic capacity for regeneration upon injury. Amniotic fluid stem cells (AFSC) have been shown to produce exosomes with growth factors and immunomodulating molecules that could stop tissue degradation and induce cartilage repair. Based on this state of the art, the main aim of this study was to explore the efficacy of the secreted exosomes, compared to their AFSC source, in MIA‐induced animal model of osteoarthritis mimicking a chronic and degenerative process, where inflammation is also involved and lead to irreversible joint damage. Exosomes, obtained by the use of a commercial kit, prior to the injection in animal knee joints, were characterized for the presence of typical markers and HGF, TGFβ, and IDO. Then, analyses were performed by histology, immunohistochemistry, and behavioral scoring up to 3 weeks after the treatment. Exosome‐treated defects showed enhanced pain tolerance level and improved histological scores than the AFSC‐treated defects. Indeed by 3 weeks, TGFβ‐rich exosome samples induced an almost complete restoration of cartilage with good surface regularity and with the characteristic of hyaline cartilage. Moreover, cells positive for resolving macrophage marker were more easily detectable into exosome‐treated joints. Therefore, a modulating role for exosomes on macrophage polarization is conceivable, as demonstrated also by experiments performed on THP1 macrophages. In conclusion, this study demonstrates for the first time the efficacy of human AFSC exosomes in counteract cartilage damage, showing a positive correlation with their TGFβ content. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
32. Hormonal contraception in women with endometriosis: a systematic review.
- Author
-
Grandi, Giovanni, Barra, Fabio, Ferrero, Simone, Sileo, Filomena Giulia, Bertucci, Emma, Napolitano, Antonella, and Facchinetti, Fabio
- Subjects
META-analysis ,CONTRACEPTION ,POSTOPERATIVE pain ,PELVIC pain ,HORMONE therapy ,CANCER hormone therapy ,TRANSVAGINAL ultrasonography - Abstract
Objective: A systematic review was carried out of studies of women with endometriosis, to examine the evidence for efficacy of the use of hormonal contraception to improve disease-related pain and decrease postoperative risk of disease recurrence.Methods: A search of the Medline/PubMed and Embase databases was performed to identify all published English language studies on hormonal contraceptive therapies (combined hormonal contraceptives [CHCs], combined oral contraceptives [COCs], progestin-only pills [POPs] and progestin-only contraceptives [POCs]) in women with a validated endometriosis diagnosis, in comparison with placebo, comparator therapies or other hormonal therapies. Main outcome measures were endometriosis-related pain (dysmenorrhoea, pelvic pain and dyspareunia), quality of life (QoL) and postoperative rate of disease recurrence during treatment.Results: CHC and POC treatments were associated with clinically significant reductions in dysmenorrhoea, often accompanied by reductions in non-cyclical pelvic pain and dyspareunia and an improvement in QoL. Only two COC preparations (ethinylestradiol [EE]/norethisterone acetate [NETA] and a flexible EE/drospirenone regimen) demonstrated significantly increased efficacy compared with placebo. Only three studies found that the postoperative use of COCs (EE/NETA, EE/desogestrel and EE/gestodene) reduced the risk of disease recurrence. There was no evidence that POCs reduced the risk of disease recurrence.Conclusions: CHCs and POCs are effective for the relief of endometriosis-related dysmenorrhoea, pelvic pain and dyspareunia, and improve QoL. Some COCs decreased the risk of disease recurrence after conservative surgery, but POCs did not. There is insufficient evidence, however, to reach definitive conclusions about the overall superiority of any particular hormonal contraceptive. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
33. The Jellyfish Sign: A New Sonographic Cervical Marker to Predict Maternal Morbidity in Abnormally Invasive Placenta Previa.
- Author
-
Bertucci, Emma, Sileo, Filomena Giulia, Grandi, Giovanni, Fenu, Valentina, Cani, Carlotta, Mancini, Luciano, Mataca, Ema, and Facchinetti, Fabio
- Published
- 2019
- Full Text
- View/download PDF
34. Amniotic Fluid Stem Cell-Derived Extracellular Vesicles Counteract Steroid-Induced Osteoporosis In Vitro.
- Author
-
Gatti, Martina, Beretti, Francesca, Zavatti, Manuela, Bertucci, Emma, Ribeiro Luz, Soraia, Palumbo, Carla, and Maraldi, Tullia
- Subjects
EXTRACELLULAR vesicles ,OSTEOPOROSIS ,AMNIOTIC liquid ,REACTIVE oxygen species ,BONE resorption ,BONE growth - Abstract
Background—Osteoporosis is characterized by defects in both quality and quantity of bone tissue, which imply high susceptibility to fractures with limitations of autonomy. Current therapies for osteoporosis are mostly concentrated on how to inhibit bone resorption but give serious adverse effects. Therefore, more effective and safer therapies are needed that even encourage bone formation. Here we examined the effect of extracellular vesicles secreted by human amniotic fluid stem cells (AFSC) (AFSC-EV) on a model of osteoporosis in vitro. Methods—human AFSC-EV were added to the culture medium of a human pre-osteoblast cell line (HOB) induced to differentiate, and then treated with dexamethasone as osteoporosis inducer. Aspects of differentiation and viability were assessed by immunofluorescence, Western blot, mass spectrometry, and histological assays. Since steroids induce oxidative stress, the levels of reactive oxygen species and of redox related proteins were evaluated. Results—AFSC-EV were able to ameliorate the differentiation ability of HOB both in the case of pre-osteoblasts and when the differentiation process was affected by dexamethasone. Moreover, the viability was increased and parallelly apoptotic markers were reduced. The presence of EV positively modulated the redox unbalance due to dexamethasone. Conclusion—these findings demonstrated that EV from hAFSC have the ability to recover precursor cell potential and delay local bone loss in steroid-related osteoporosis. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
35. Unravelling Heterogeneity of Amplified Human Amniotic Fluid Stem Cells Sub-Populations.
- Author
-
Casciaro, Francesca, Zia, Silvia, Forcato, Mattia, Zavatti, Manuela, Beretti, Francesca, Bertucci, Emma, Zattoni, Andrea, Reschiglian, Pierluigi, Alviano, Francesco, Bonsi, Laura, Follo, Matilde Yung, Demaria, Marco, Roda, Barbara, and Maraldi, Tullia
- Subjects
AMNIOTIC liquid ,STEM cells ,FIELD-flow fractionation ,GENE expression profiling ,PROGENITOR cells ,P53 protein - Abstract
Human amniotic fluid stem cells (hAFSCs) are broadly multipotent immature progenitor cells with high self-renewal and no tumorigenic properties. These cells, even amplified, present very variable morphology, density, intracellular composition and stemness potential, and this heterogeneity can hinder their characterization and potential use in regenerative medicine. Celector
® (Stem Sel ltd.) is a new technology that exploits the Non-Equilibrium Earth Gravity Assisted Field Flow Fractionation principles to characterize and label-free sort stem cells based on their solely physical characteristics without any manipulation. Viable cells are collected and used for further studies or direct applications. In order to understand the intrapopulation heterogeneity, various fractions of hAFSCs were isolated using the Celector® profile and live imaging feature. The gene expression profile of each fraction was analysed using whole-transcriptome sequencing (RNAseq). Gene Set Enrichment Analysis identified significant differential expression in pathways related to Stemness, DNA repair, E2F targets, G2M checkpoint, hypoxia, EM transition, mTORC1 signalling, Unfold Protein Response and p53 signalling. These differences were validated by RT-PCR, immunofluorescence and differentiation assays. Interestingly, the different fractions showed distinct and unique stemness properties. These results suggest the existence of deep intra-population differences that can influence the stemness profile of hAFSCs. This study represents a proof-of-concept of the importance of selecting certain cellular fractions with the highest potential to use in regenerative medicine. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
36. Surface Rendering of External Genitalia of a Fetus at the 32nd Week of Gestation Affected by Partial Androgen Insensitivity Syndrome.
- Author
-
Mazza, Vincenzo, Bertucci, Emma, Latella, Silvia, Cani, Carlotta, Ceccarelli, Pierluca, Iughetti, Lorenzo, Baldinotti, Fulvia, and Percesepe, Antonio
- Subjects
- *
VULVA , *FETUS , *GESTATIONAL age , *ANDROGEN-insensitivity syndrome , *PRENATAL diagnosis , *KARYOTYPES , *ULTRASONIC imaging - Abstract
Objectives. To demonstrate the feasibility of the prenatal diagnosis of partial androgen insensitivity syndrome by 3D-4D ultrasound. Methods. To report prenatal diagnosis of partial androgen insensitivity syndrome at 32nd week of gestation by 3D-4D ultrasound in a fetus with a 46XY karyotype, testing negative to the mutation analysis of SRY gene and the 5ɑ-reductase 2 gene (SRD5A2). Results. 3D-4D surface rendering allows the detection of external and internal genital malformations and can address the prenatal diagnosis of PAIS and can exclude associated complications. Conclusions. Prenatal diagnosis of PAIS allows an adequate parental counseling and an early optimal management of the condition, not only for the psychological and social reflections but also for the avoidance of complications and postnatal morbidity due to misdiagnosis or delays in the treatment of the genital ambiguity [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
37. Second trimester amniocentesis is not a risk factor for very low birth weight and extremely low birth weight.
- Author
-
Mazza, Vincenzo, Pati, Mariangela, Bertucci, Emma, Cani, Carlotta, Latella, Silvia, Gargano, Giancarlo, Percesepe, Antonio, and Volpe, Annibale
- Subjects
AMNIOCENTESIS ,LOW birth weight ,OBSTETRICS surgery ,PREMATURE infants ,SECOND trimester of pregnancy - Abstract
Objectives. To assess the risk of very low birth weight (VLBW) and extremely low birth weight (ELBW) attributable to second trimester amniocentesis. Methods. Records of 4,877 consecutive amniocentesis, performed between 1997 and 2003, were analyzed. Only VLBW and ELBW in the study population (exposed) and in the control group (unexposed) were evaluated. Comparisons were made between the amniocentesis group versus nonexposed. Odds ratios (OR) and 95% confidence intervals (95% CI) were calculated for VLBW and ELBW classes. Results. In the study population, the VLBW were 35 (0.71%) and the ELBW were 20 (0.41%). In the control group, the VLBW were 220 (0.67%) and the ELBW were 112 (0.34%). The Odds ratios of the VLBW between the study and the control group did not show any statistical significant risk (OR = 1.07, 95% CI = 0.72-1.54). Also in ELBW odds ratios between study and control group were not statistically significant (OR = 1.20, 95% CI = 0.7-1.95). Conclusions. No effect of the second trimester amniocentesis was noted on VLBW and ELBW. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
38. MRI of placenta accreta: diagnostic accuracy and impact of interventional radiology on foetal–maternal delivery outcomes in high-risk women.
- Author
-
Fiocchi, Federica, Monelli, Filippo, Besutti, Giulia, Casari, Federico, Petrella, Elisabetta, Pecchi, Annarita, Caporali, Cristian, Bertucci, Emma, Busani, Stefano, Botticelli, Laura, Facchinetti, Fabio, and Torricelli, Pietro
- Subjects
FLUOROSCOPY ,INTERVENTIONAL radiology ,ERYTHROCYTES ,PLACENTA ,INVASIVE diagnosis ,LOCAL delivery services ,LYMPHOCYTE count - Abstract
To assess accuracy and reproducibility of MRI diagnosis of invasive placentation (IP) in high-risk patients and to evaluate reliability of MRI features. Secondary aim was to evaluate impact of interventional radiology (IR) on delivery outcomes in patients with IP at MRI. 26 patients (mean age 36.24 y/o,SD 6.16) with clinical risk-factors and echographic suspicion of IP underwent 1.5 T-MRI. Two readers reviewed images. Gold-standard was histology in hysterectomised patients and obstetric evaluation at delivery for patients with preserved uterus. Accuracy and reproducibility of MRI findings were calculated. Incidence of IP was 50% (13/26) and of PP was 11.54% (3/26). MRI showed 100% sensitivity (95% CI = 75.3–100%) and 92.3% specificity (95% CI = 64.0–100%) in the diagnosis of IP. Gold-standard was histology in 10 cases and obstetric evaluation in 16. MRI findings with higher sensitivity were placental heterogeneity, uterine bulging and black intraplacental bands. Uterine scarring, placental heterogeneity, myometrial interruption and tenting of the bladder showed better specificity. MRI inter-rater agreement with Cohen's K was 1. 11 patients among 14 with MRI diagnosis of IP received IR assistance with positive impact on delivery outcomes in terms of blood loss, red cells count, intense care unit length of stay, days of hospitalisation and risk of being transfused. MRI is an accurate and reproducible technique in prenatal diagnosis of IP. MRI helps planning a safe and appropriate delivery eventually assisted by IR, which positively affects foetal and maternal outcomes. The adoption of MRI evaluation in patients with high risk of invasive placentation allows a more accurate diagnosis in terms of both presence of the disease and its extension to or through or even beyond the myometrium. This led to a better dedicated delivery management with eventual adoption of interventional radiology with a global positive effect on foetal and maternal outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
39. Fetal hepatic calcification in severe KAT6A (Arboleda-Tham) syndrome.
- Author
-
Di Caprio, Antonella, Rossi, Cecilia, Bertucci, Emma, Bedetti, Luca, Bertoncelli, Natascia, Miselli, Francesca, Corso, Lucia, Bondi, Carolina, Iughetti, Lorenzo, Berardi, Alberto, and Lugli, Licia
- Subjects
- *
PHENOTYPIC plasticity , *SYNDROMES , *INTELLECTUAL disabilities , *GENETIC disorders , *MEDICAL research , *CALCIFICATION , *RECESSIVE genes , *CALCIFICATIONS of the breast - Abstract
Arboleda-Tham syndrome (ARTHS, MIM 616268) is a rare genetic disease, due to a pathogenic variant of Lysine (K) Acetyltransferase 6A (KAT6A) with autosomal dominant inheritance. Firstly described in 2015, ARTHS is one of the more common causes of undiagnosed syndromic intellectual disability. Due to extreme phenotypic variability, ARTHS clinical diagnosis is challenging, mostly at early stage of the disease. Moreover, because of the wide and unspecific spectrum of ARTHS, identification of the syndrome during prenatal life rarely occurs. Therefore, reported cases of KAT6A syndrome have been identified primarily through clinical or research exome sequencing in a gene-centric approach. In order to expands the genotypic and phenotypic spectrum of ARTHS, we describe prenatal and postnatal findings in a patient with a novel frameshift KAT6A pathogenic variant, displaying a severe phenotype with previously unreported clinical features. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. First-trimester ultrasonographic diagnosis of Langer mesomelic dysplasia in a previously affected family.
- Author
-
Mazza V, Latella S, Pati M, Re C, Bertucci E, Cani C, Percesepe A, Mazza, Vincenzo, Latella, Silvia, Pati, Mariangela, Re, Claudia, Bertucci, Emma, Cani, Carlotta, and Percesepe, Antonio
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.